Growth factors and psychiatric disorders

摘要: Symposium on Growth factors and psychiatric disorders, held at the Novartis Foundation, London, 20-22 March 2007. Editors: Derek J. Chadwick (Organizer) Jamie Goode. This symposium is based a proposal made by Moses Chao. Chao Chair's introduction. Daniel C. Javitt Phenomenology, aetiology treatment of schizophrenia. Discussion. Jonathan Flint, Sagiv Shifman, Marcus Munafo Richard Mott Genetic variants in major depression. Eero Castren Tomi Rantamaki Neurotrophins depression antidepressant effects. Jinbo Fan Pamela Sklar Genetics bipolar disorder: focus BDNF Val66Met polymorphism. David A. Talmage Mechanisms neuregulin action. General discussion I. H. Akil, S. Evans, Turner, Perez, R. M. Myers, W. E. Bunney, G. Jones, Watson other members Pritzker Consortium The fibroblast growth factor family mood disorders. Jay N. Giedd, Rhoshel K. Lenroot, Philip Shaw, Francois Lalonde, Mark Celano, Samantha White, Julia Tossell, Anjene Addington Nitin Gogtay Trajectories anatomic brain development as phenotype. Bai Lu Keri Martinowich Cell biology its relevance to Enrico Tongiorgi Gabriele Baj Functions mechanisms mRNA trafficking. Amar Sahay Rene Hen Hippocampal neurogenesis Andres Buonanno, Oh-Bin Kwon, Leqin Yan, Carmen Gonzalez, Marines Longart, Dax Hoffman Detlef Vullhorst Neuregulins neuronal plasticity: possible Zhe-Yu Chen, Kevin Bath, Bruce McEwen, Barbara Hempstead Francis Lee Impact genetic variant (Val66Met) structure function. II. D. Malaspina, Perrin, Kleinhaus, Opler Harlap schizophrenia: aetiology, epidemiology epigenetics. Luiz Camargo, Qi Wang Nicholas Brandon What can we learn from disrupted schizophrenia 1 interactome: lessons for target identification disease biology? Michael Spedding Pierre Gressens cytokines plasticity. Closing remarks. Index contributors. Subject index.